Hims Hair (Finasteride + Minoxidil)vsHappy Head Prescription Topical

Hims Hair targets male-pattern baldness two ways at once. Finasteride blocks the enzyme 5-alpha-reductase, which converts testosterone into DHT, the hormone that shrinks genetically susceptible scalp follicles; lowering scalp DHT slows that miniaturization. Minoxidil works on a different pathway, widening blood vessels and prolonging the follicle's active growth (anagen) phase to reactivate dormant follicles and thicken existing hairs. Used together as a daily scalp spray, they aim to slow loss (finasteride) while stimulating regrowth (minoxidil).

Happy Head's topical targets hair loss two ways at once. Minoxidil widens scalp blood vessels and is converted by an enzyme in the follicle (sulfotransferase) into its active form, which prolongs the hair's growth (anagen) phase and can thicken strands. Finasteride blocks 5-alpha-reductase, the enzyme that turns testosterone into DHT, the hormone that shrinks genetically susceptible follicles. Applied to the scalp, finasteride lowers scalp DHT while keeping blood levels much lower than the oral pill. Add-ons such as retinoic acid (tretinoin) are intended to aid minoxidil penetration, while hydrocortisone or ketoconazole may help calm scalp irritation and inflammation.

The active ingredients are individually well-validated. In the pivotal oral finasteride 1mg trials cited on the Propecia FDA label, 48% of men had increased hair count at 12 months versus 7% on placebo; in 5-year data, 48% showed increased growth, 42% had no further loss, and about 10% continued losing. For topical minoxidil, a 393-man, 48-week randomized trial found 5% minoxidil produced roughly 45% more regrowth than 2% minoxidil by target-area hair counts. Combining a 5-alpha-reductase inhibitor with minoxidil generally outperforms either alone. Important caveat: Hims' specific compounded 0.3% topical finasteride / 6% minoxidil spray has not been studied in large dedicated FDA trials, so its exact regrowth numbers are inferred from the individual drugs, not proven for this product.

The individual ingredients are well-studied, though Happy Head has not published a peer-reviewed trial of its specific product. Topical minoxidil (2% and 5%) is the only FDA-approved topical for androgenetic alopecia, with randomized trials consistently showing increased hair counts. A phase III randomized, placebo-controlled trial of a topical finasteride spray (Piraccini et al., published 2022) found a +20.2 vs +6.7 adjusted mean hair-count change versus placebo at 24 weeks (P<0.001), an effect similar to oral finasteride but with maximum plasma drug levels more than 100 times lower; serum DHT fell about 34.6% with the topical versus 55.6% with oral finasteride. A 2025 systematic review and meta-analysis of randomized controlled trials found topical minoxidil-finasteride combinations outperformed minoxidil alone on hair density and diameter. Note that this evidence is for similar compounded or spray formulations, not Happy Head's exact product, and the company's before/after photos are marketing testimonials, not controlled data. Most users who respond see results in roughly 3 to 6 months.

Local effects are most common: scalp itching, dryness, flaking, redness, or irritation from the alcohol/minoxidil base, plus possible unwanted facial hair if the product migrates. Minoxidil can cause a temporary early shed in the first weeks. Finasteride's known risks include decreased libido, erectile dysfunction, and ejaculation disorders (roughly 1-2% in oral trials, modestly above placebo). Serious or rarer concerns on the FDA finasteride label include depression, suicidal ideation, gynecomastia, and sexual side effects that can persist after stopping (sometimes called post-finasteride syndrome). Critically, in April 2025 the FDA alerted clinicians and consumers about compounded topical finasteride after reports of erectile dysfunction, anxiety, suicidal ideation, brain fog, depression, fatigue, insomnia, decreased libido, and testicular pain, many of which continued after discontinuation; topical use lowers but does not eliminate systemic absorption. Minoxidil can rarely cause dizziness or rapid heartbeat. Stop and seek care for chest pain, swelling, fainting, or mood changes.

Common local effects include scalp redness, itching, burning, dryness, and flaking, plus a temporary increase in shedding in the first 6 to 8 weeks of minoxidil use (often a transient phase as follicles cycle, though persistent or heavy shedding warrants checking with your prescriber). Propylene-glycol-containing bases can trigger contact dermatitis, and higher 8% minoxidil may irritate more than standard 5%. The finasteride component, though absorbed far less than the pill, can still cause systemic effects: in April 2025 the FDA issued a safety alert about compounded topical finasteride, citing 32 adverse-event reports (2019-2024) including erectile dysfunction, decreased libido, depression, anxiety, suicidal ideation, brain fog, fatigue, insomnia, and testicular pain, and noting that most reports described effects that persisted after stopping. Report any mood changes, sexual dysfunction, chest symptoms, or unwanted facial or body hair growth to your prescriber promptly.

As of 2026, the Hims topical finasteride + minoxidil spray starts around $35/month, with the lowest per-month price when billed and shipped on a longer (for example, multi-month) cycle. For comparison, Hims oral finasteride runs about $22/month and standalone minoxidil about $15/month. There may also be a low-cost or one-time medical consultation fee. These are cash-pay telehealth/compounded products, so insurance typically does not cover them; generic oral finasteride filled at a pharmacy with a prescription can sometimes be cheaper (often around $10-25/month with discount cards) for those who do not need the topical convenience.

As of 2026, Happy Head's topical finasteride-and-minoxidil solution is priced at about $49 for a promotional first order, then roughly $63 per month on a subscription (about $79 as a one-time purchase). More complex multi-ingredient formulas and bundles (for example with dutasteride, liposomal delivery, or an added oral SuperCapsule) cost more, commonly ranging from about $79 up to roughly $178 per month depending on the combination. A 6-month satisfaction guarantee refunds your most recent month's supply if you are unhappy, and you can pause, skip, or cancel anytime. Because these are compounded prescriptions, insurance reimbursement is unlikely, though FSA/HSA cards may be accepted; expect to pay out of pocket. For comparison, generic 5% minoxidil alone runs roughly $10 to $15 per month, so you are paying a premium for the added finasteride, customization, and telehealth service.

Designed for adult men (typically 18+) with mild-to-moderate male-pattern hair loss, especially at the crown/vertex and frontal areas; earlier treatment generally protects more hair. It requires a telehealth medical evaluation before a clinician decides whether to prescribe it. Finasteride is not approved for and should not be used by women, and it must never be handled by anyone who is or may become pregnant because of the risk of birth defects in a male fetus. Avoid if you have a finasteride or minoxidil allergy; men planning to conceive, with a history of depression, or with liver or cardiovascular concerns should discuss the risks with a clinician first.

Best for adults with early-to-moderate androgenetic alopecia (male- or female-pattern thinning) who want combination minoxidil-plus-finasteride therapy but prefer a topical over an oral pill, or who did not tolerate oral finasteride's systemic side effects. A telehealth dermatologist reviews each case and customizes the formula. Who should avoid it: anyone who is pregnant, breastfeeding, or may become pregnant must not handle finasteride or dutasteride (risk of birth defects in a male fetus). People with cardiovascular disease or low blood pressure should be cautious with high-dose minoxidil and talk to a doctor first, and those with a history of depression or sexual dysfunction should weigh finasteride's potential mood and sexual side effects with their prescriber. It is not appropriate for scarring alopecia, sudden or patchy total hair loss, or undiagnosed shedding; see a doctor for an evaluation first.